Strategic Blueprint’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-145
Closed -$23K 558
2021
Q2
$23K Buy
+145
New +$23K ﹤0.01% 757